LumiraDx Limited (NASDAQ: LMDX) on November 20, 2023, started off the session at the price of $0.1307, plunging -8.22% from the previous trading day. During the day, the shares moved up to $0.135 and dropped to $0.119 before settling in for the closing price of $0.14. Within the past 52 weeks, LMDX’s price has moved between $0.08 and $1.61.
A company in the Healthcare sector has jumped its sales by 81.62% annually for the last half of the decade. The company achieved an average annual earnings per share of 33.75%.
In terms of profitability, gross margin is -14.65, operating margin of -126.32, and the pretax margin is -173.45.
LumiraDx Limited (LMDX) Insider Updates
Observing investor behavior towards Diagnostics & Research industry stocks is more important than anything else. The insider ownership of LumiraDx Limited is 86.34%, while institutional ownership is 9.91%.
LumiraDx Limited (LMDX) Performance Highlights and Predictions
As on 6/29/2023, Multinational firm has announced its last quarter scores, in which it reported -$0.16 earnings per share (EPS) for the period falling under the consensus outlook (set at -$0.14) by -$0.02. This company achieved a net margin of -176.59 while generating a return on equity of -1,754.85. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.09 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 33.75% per share during the next fiscal year.
LumiraDx Limited (NASDAQ: LMDX) Trading Performance Indicators
LumiraDx Limited (LMDX) is currently performing well based on its current performance indicators. A quick ratio of 1.01 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.35.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.09, a number that is poised to hit -0.11 in the next quarter and is forecasted to reach -0.38 in one year’s time.
Technical Analysis of LumiraDx Limited (LMDX)
Let’s dig in a bit further. During the last 5-days, its volume was 22.34 million. That was better than the volume of 3.39 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 62.13%. Additionally, its Average True Range was 0.03.
During the past 100 days, LumiraDx Limited’s (LMDX) raw stochastic average was set at 10.79%, which indicates a significant decrease from 53.82% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 180.34% in the past 14 days, which was lower than the 235.66% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.1753, while its 200-day Moving Average is $0.4929. However, in the short run, LumiraDx Limited’s stock first resistance to watch stands at $0.1329. Second resistance stands at $0.1420. The third major resistance level sits at $0.1489. If the price goes on to break the first support level at $0.1169, it is likely to go to the next support level at $0.1100. Assuming the price breaks the second support level, the third support level stands at $0.1009.
LumiraDx Limited (NASDAQ: LMDX) Key Stats
Market capitalization of the company is 44.83 million based on 318,546K outstanding shares. Right now, sales total 254,480 K and income totals -447,790 K. The company made 21,000 K in profit during its latest quarter, and -49,740 K in sales during its previous quarter.